Vaccine developments.
Liu
M A
MA
Chiron Vaccines Research, Meryville, California 94608, USA.
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D001428:Bacterial Vaccines; D002681:China; D005060:Europe; D016678:Genome; D006001:Glycoconjugates / Q000276:immunology; D000882:Haplorhini; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049690:History, Ancient; D007156:Immunologic Memory; D016233:Immunotherapy, Active; D010455:Peptides / Q000276:immunology; D030821:Plants, Genetically Modified; D012093:Replicon; D018449:SAIDS Vaccines; D013045:Species Specificity; D014611:Vaccination / Q000266:history / Q000379:methods; D014612:Vaccines / Q000266:history; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D006001:Glycoconjugates; D010455:Peptides; D018449:SAIDS Vaccines; D014612:Vaccines; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D014765:Viral Vaccines